GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

If you're headed into the end of 2024 with a large FSA balance, don't worry. A long list of items and health services are FSA ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Department store chain Nordstrom (JWN) has accepted a $6.25 billion all-cash buyout offer to end its 53-year run as a publicly traded company.

The outcome means the case could be tried again in the future - something Arm vowed to pursue in a statement following the ...

Smiths Group benefits from a high proportion of aftermarket revenue that is sticky and high profit margin. Smiths Group’s balance sheet remains in good financial condition, with net debt of GBP 213 ...